Literature DB >> 29705706

Respective roles of the mitogen-activated protein kinase (MAPK) family members in pancreatic stellate cell activation induced by transforming growth factor-β1 (TGF-β1).

Xiao-Fan Xu1, Fang Liu2, Jia-Qi Xin2, Jian-Wei Fan2, Nan Wu2, Lin-Jia Zhu2, Li-Fang Duan2, Yong-Yu Li3, Hong Zhang4.   

Abstract

Activated pancreatic stellate cells (PSCs) play a crucial role in the progression of pancreatic fibrosis. Transforming growth factor-β (TGF-β) is one of the strongest stimulator inducing fibrosis. The mitogen-activated protein kinase (MAPK) proteins (including ERK, JNK and p38 MAPK) are known to contribute to PSC activation and pancreatic fibrosis. Previous studies have identified PSC activation induced by TGF-β1 is related to MAPK pathway, but the respective role of MAPK family members in PSC activation still unclear, and which family member may be the key mediator in mice PSC activation still controversial. In this study, we investigated the influence of different MAPK family member (JNK, ERK, and p38 MAPK) on mice PSC activation using an in vivo and in vitro model. The results showed p-JNK, p-ERK and p-p38 MAPK were all over-expressed in CP group, and p-JNK, p-ERK, and p-p38 MAPK were co-expressed with activated PSC. In vitro, TGF-β1 induced JNK and ERK over-expression in PSCs. In contrast, p38 MAPK expression in PSC showed only a very weak increase. JNK- and ERK-specific inhibitors inhibited FN and α-SMA mRNA expression in PSCs, and a p38 MAPK inhibitor had no effect on PSC activation. These findings indicate that JNK and ERK were directly involved in the PSCs activation induced by TGF-β1 and the development of pancreatic fibrosis. p38 MAPK participate in the progression of CP, but it does not respond to TGF-β1 directly and may not be regarded as the target of TGF-β1 induced PSC activation.
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Keywords:  Mitogen activated protein kinase; Pancreatic fibrosis; Pancreatic stellate cells; Transforming growth factor-β

Mesh:

Substances:

Year:  2018        PMID: 29705706     DOI: 10.1016/j.bbrc.2018.04.176

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

1.  Postoperative peritoneal adhesion: an update on physiopathology and novel traditional herbal and modern medical therapeutics.

Authors:  Setareh Soltany
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2020-09-26       Impact factor: 3.000

Review 2.  Pancreatic stellate cells - rising stars in pancreatic pathologies.

Authors:  P Hrabák; M Kalousová; T Krechler; T Zima
Journal:  Physiol Res       Date:  2021-12-30       Impact factor: 2.139

3.  HDAC inhibitors promote pancreatic stellate cell apoptosis and relieve pancreatic fibrosis by upregulating miR-15/16 in chronic pancreatitis.

Authors:  Ting Ji; Weiguang Feng; Xiangcheng Zhang; Kui Zang; Xingxing Zhu; Futai Shang
Journal:  Hum Cell       Date:  2020-06-11       Impact factor: 4.174

4.  Naringin ameliorates memory deficits and exerts neuroprotective effects in a mouse model of Alzheimer's disease by regulating multiple metabolic pathways.

Authors:  Xiangdong Meng; Mingming Fu; Shoufeng Wang; Weida Chen; Jianjie Wang; Ning Zhang
Journal:  Mol Med Rep       Date:  2021-03-24       Impact factor: 2.952

5.  Orai1 Channel Regulates Human-Activated Pancreatic Stellate Cell Proliferation and TGFβ1 Secretion through the AKT Signaling Pathway.

Authors:  Silviya Radoslavova; Antoine Folcher; Thibaut Lefebvre; Kateryna Kondratska; Stéphanie Guénin; Isabelle Dhennin-Duthille; Mathieu Gautier; Natalia Prevarskaya; Halima Ouadid-Ahidouch
Journal:  Cancers (Basel)       Date:  2021-05-15       Impact factor: 6.639

6.  Chaihu Guizhi Ganjiang Decoction Ameliorates Pancreatic Fibrosis via JNK/mTOR Signaling Pathway.

Authors:  Lihua Cui; Caixia Li; Ye Shang; Dihua Li; Yuzhen Zhuo; Lei Yang; Naiqiang Cui; Yuhong Li; Shukun Zhang
Journal:  Front Pharmacol       Date:  2021-06-10       Impact factor: 5.810

7.  Puerarin Ameliorates Caerulein-Induced Chronic Pancreatitis via Inhibition of MAPK Signaling Pathway.

Authors:  Xiang-Peng Zeng; Jing-Hui Zeng; Xia Lin; Yan-Hong Ni; Chuan-Shen Jiang; Da-Zhou Li; Xiao-Jian He; Rong Wang; Wen Wang
Journal:  Front Pharmacol       Date:  2021-06-02       Impact factor: 5.810

8.  Mild microwave ablation combined with HSP90 and TGF‑β1 inhibitors enhances the therapeutic effect on osteosarcoma.

Authors:  Lingling Chen; Ming Wang; Zefeng Lin; Mengyu Yao; Wanshun Wang; Shi Cheng; Binglin Li; Yu Zhang; Qingshui Yin
Journal:  Mol Med Rep       Date:  2020-05-22       Impact factor: 2.952

9.  Isoliquiritigenin ameliorates caerulein-induced chronic pancreatitis by inhibiting the activation of PSCs and pancreatic infiltration of macrophages.

Authors:  Li-Juan Wang; Lin He; Lu Hao; Hong-Lei Guo; Xiang-Peng Zeng; Ya-Wei Bi; Guo-Tao Lu; Zhao-Shen Li; Liang-Hao Hu
Journal:  J Cell Mol Med       Date:  2020-07-17       Impact factor: 5.310

Review 10.  Molecular mechanisms of pancreatic myofibroblast activation in chronic pancreatitis and pancreatic ductal adenocarcinoma.

Authors:  Andrew Cannon; Christopher Michael Thompson; Rakesh Bhatia; Katharine Anne Armstrong; Joyce Christopher Solheim; Sushil Kumar; Surinder Kumar Batra
Journal:  J Gastroenterol       Date:  2021-07-19       Impact factor: 6.772

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.